As of 2025-05-18, the Intrinsic Value of Forward Pharma A/S (FWP) is -1.97 USD. This FWP valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.95 USD, the upside of Forward Pharma A/S is -200.89%.
Based on its market price of 1.95 USD and our intrinsic valuation, Forward Pharma A/S (FWP) is overvalued by 200.89%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -1.97 - -1.97 | -1.97 | -200.89% |
P/E | (3.56) - (3.14) | (3.40) | -274.5% |
DDM - Stable | (2.96) - (8.60) | (5.78) | -396.5% |
DDM - Multi | (1.01) - (2.34) | (1.42) | -172.8% |
Market Cap (mil) | 20.92 |
Beta | 1.40 |
Outstanding shares (mil) | 10.73 |
Enterprise Value (mil) | -49.85 |
Market risk premium | 5.00% |
Cost of Equity | 10.70% |
Cost of Debt | 5.00% |
WACC | 7.75% |